🌏 Asia 1d ago

Biocon gets launch clarity for breast cancer biosimilar after Genentech deal

The Hindu Business Line
View Channel →
Biocon gets launch clarity for breast cancer biosimilar after Genentech deal
Source ↗ 👁 0 💬 0
The company is targeting the first quarter of 2027 for launches in the European Union and the UK, followed by the US in the third quarter of 2028

Comments (0)

Sign in to join the discussion

More Like This

FACT CHECK: Martin Romualdez remains detained in Payatas jail
RAPPLER · 14h ago
📰
Q2 Results Today Live: Nestle Q2 PAT up 36% y-o-y, Polycab profit rises 44%, Wipro, Tech Mahindra, Jio Financial, IRFC, HDFC AMC, HDFC Life, Tata Communications, KVB, IIFL, Persistent Systems, 360 ONE WAM, Angel One to announce Q2 results
Business News Today: Latest Business News, Finance News · 14h ago
India’s festive shopping surge leaves metros behind as small cities lead the charge
Business News Today: Latest Business News, Finance News · 14h ago
📰
Sensex today | Stock Market Live: Sensex jumps 1,388 pts, Nifty above 23,000; TechM, HCL lead gainers
Business News Today: Latest Business News, Finance News · 14h ago
World Bank Group mobilises $36 billion in India in four years, $9.6 billion for MSMEs
Business News Today: Latest Business News, Finance News · 14h ago
Fairfax’s ₹52,878 crore bank deal signals zest for India assets
Business News Today: Latest Business News, Finance News · 14h ago